ArticleNew California Law Adds Single-Firm Conduct To Cartwright Act: Unilateral Actors Can Be Liable For State Antitrust Violations In Suits Brought By State Enforcers23 October 2026United States · Antitrust/Competition Law
ArticleSEC Proposes Interval Fund Updates, Extension Of Multi-Class Relief For Closed-End Funds And BDCs21 October 2026United States · Finance and Banking
ArticleNo Defect, No Duty: California Supreme Court Reaffirms The Bedrock Of Products Liability Law16 October 2026United States · Consumer Protection
ArticleNew York Climate Superfund Law Struck Down As Federally Preempted16 October 2026United States · Environment
ArticleSEC Proposes To Significantly Expand Performance Fee Eligibility16 October 2026United States · Finance and Banking
ArticleConnecticut Court Sanctions Litigant For Hidden “Prompt-Injection” Text In Filings16 October 2026United States · Litigation, Mediation & Arbitration
ArticleSecond Circuit Delivers A Mixed Verdict On Phenylephrine Preemption15 October 2026United States · Litigation, Mediation & Arbitration
ArticleD.C. Circuit Rebuffs Challenge To EPA’s PFOA And PFOS Hazardous Substance Rule15 October 2026United States · Environment
ArticleNo Diagnosis, No Recommendation, No Recovery: California Court Rejects Explant-Only Injury In Allergan BIOCELL Bellwethers15 October 2026United States · Litigation, Mediation & Arbitration
ArticleSEC Proposes To Rescind Rule 14a-8, Modernize Proxy Rules09 October 2026United States · Corporate/Commercial Law
ArticleSEC Issues “Innovation Exemption” To Facilitate Trading Of Tokenized NMS Stock02 October 2026United States · Finance and Banking
ArticleLP-Led CFOs: Their Rise And Key Considerations29 September 2026United States · Finance and Banking
ArticleFive Takeaways From The Private Credit Summit – New York28 September 2026United States · Finance and Banking
ArticleABS Market Update: SEC Expands Confidential Draft Registration Review For ABS Issuers25 September 2026United States · Finance and Banking
ArticleSEC Opens Door To Exchange-Listed, Tokenized Interval Fund Shares24 September 2026United States · Finance and Banking
ArticleConcierge Medicine And Medical Aesthetics: The Private Equity Playbook For A US$590 Billion Opportunity18 September 2026United States · Food, Drugs, Healthcare, Life Sciences
ArticleDuration Is Not Destiny: The NAIC's Proposal For Multi-Collateral Structured Credit Investments10 September 2026United States · Finance and Banking
Article340B Meets The FCA In The Ninth Circuit: What The Pharmaceutical Industry And Investors Need To Know OnPoint Thu Sep 03 2026 The Ninth Circuit's Adventist Decision Lets 340B Covered Entities Bring FCA Qui Tam Suits Over Drug Pricing, Raising New Risks For Manufacturers And Investors.09 September 2026United States · Corporate/Commercial Law